AIM: To identify survival prognostic factors in patients who underwent curative pelvic exenteration from rectal adenocarcinoma (T4 tumors and isolated pelvic recurrence). METHODS: Complete follow-up data were available on 27 patients who underwent this surgical procedure between 1996 and 2006. Multiple prognostic factors were studied by multivariate analysis (epidemiological, surgical and histological). RESULTS: Postoperative mortality was 7 % (n=2) while overall morbidity was 55 % (n=15). Mean of overall survival was 38 months. T4 tumors presented more long-time survival than pelvic recurrence (47 X 26 months). Lymph node disease (N+) was single adverse prognostic factor at multivariate analysis. CONCLUSION: Pelvic exenteration presents both high morbidity and considerable mortality. It should be reserved for T4 tumors, principally when there was no lymph node spreading.
Pelvic Exenteration; Rectal Cancer; Prognostic Factors; Morbidity; Mortality; Treatment Outcome
